Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,251-1,275 of 2,022
CompletedNCT07173465

Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 77 Years
Countries
Turkey
Sponsor
Yeditepe University
Condition
Schizophrenia
CompletedNCT07165821

Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand what helps a medication treatment stay useful, realistic, and easier to follow over time.

SchizophreniaOtherFrom 20 Years to 59 Years
Countries
Thailand
Sponsor
Suranaree University of Technology
Condition
Schizophrenia
CompletedNCT06276361

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Jordan
Sponsor
Rovi Pharmaceuticals Laboratories
Condition
Schizophrenia
CompletedNCT03681145

Youth to Text or Telehealth for Engagement in HIV Care

This study exists to see whether acceptance and commitment therapy, a talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can work better when mental health difficulties overlap with substance use.

DepressionOtherFrom 18 Years to 29 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
CompletedNCT03314129

Remediation of Visual Perceptual Impairments in People With Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Rochester
Condition
Schizophrenia
CompletedNCT07150507

The Effectiveness of Breathing Therapy in Patients With Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Turkey
Sponsor
Ataturk University
Condition
Schizophrenia
CompletedNCT04166019

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Chinese University of Hong Kong
Condition
Schizophrenia
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This study exists to understand how the medication Pimavanserin holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherOver 18 Years
Countries
Argentina, Bulgaria, Canada, Croatia, Czech Republic, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine, United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
CompletedNCT04531982

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Argentina, Bulgaria, Croatia, Czech Republic, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
TerminatedNCT02853019

Emotion and Motivation in Patients With Psychosis

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
CompletedNCT07130227

MBRS-Based Psychoeducation in Patients With Schizophrenia

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand what psychoeducation, a guided learning and support program, could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Turkey
Sponsor
Ataturk University
Condition
Schizophrenia
CompletedNCT06574893

Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Turkey
Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Condition
Schizophrenia
CompletedNCT07116850

Adjunctive iTBS for First-Episode Schizophrenia

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
The First Hospital of Hebei Medical University
Condition
Schizophrenia
CompletedNCT04325386

Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 22 Years to 85 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT01490086

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
India, Malaysia, Moldova, Philippines, United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
CompletedNCT07111689

The Effect of Virtual Reality on Cognitive Skills in Schizophrenia

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Saglik Bilimleri Universitesi
Condition
Schizophrenia
TerminatedNCT05501405

Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 10 Years to 50 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
TerminatedNCT06397950

Correlates of Fatigue in People With Schizophrenia

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
GCS CIPS
Condition
Schizophrenia
CompletedNCT04025905

Social Cognition Training and Vocational Rehabilitation

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia